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Introduction: Studies have reported an association between lipoprotein lipase (LPL) gene and
myocardial infarction in some populations. Therefore, the present study aimed to inves-
tigate the association of the HindIII polymorphism of the (LPL) gene with myocardial
infarction and to explore its potential role in susceptibility in a South Indian population.
Subjects and methods:We included a total of 412 subjects (202 myocardial infarction patients
and 210 age- and sex-matched controls). Demographic and clinical characteristics were
collected. Lipid profiles were estimated. DNA was isolated and the LPL gene HindIII poly-
morphism was determined by polymerase chain reaction.
Results: Comparison of the lipid profiles between patients and controls showed that pa-
tients had statistically high significant values (p ¼ 0.0001). The Hþ Hþ genotype of the LPL
gene is associated with myocardial infarction. Hþ Hþ vs. H Hwas c2 ¼ 19.4, OR 3.1, CI 95%
1.8e5.2, p < 0.0001.
Conclusion: Our study strongly suggests that the LPL gene HindIII Hþ Hþ genotype is an
independent risk factor for first MI.
Copyright ª 2013, Cardiological Society of India. All rights reserved.1. Introduction rupture with thrombus formation in a coronary vessel,Myocardial Infarction (MI), also known as heart attack, is the
irreversible necrosis of heart muscle secondary to prolonged
ischemia. This usually results from an imbalance in oxygen
supply and demand, which is most often caused by plaque0688, þ91 990818308.
.in (D.K. Murthy).
2013, Cardiological Societresulting in an acute reduction of blood supply to a portion of
the myocardium. The classical symptoms of MI are shortness
of breath, chest pain anxiety typically radiating to the left arm
or left side of the neck, palpitations and vomiting. The
important risk factors are previous history of vascular diseasey of India. All rights reserved.
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age e especially in men over 40 and women over 50 years.1
Lipoprotein lipase (LPL) plays a important role in lipid
metabolism by hydrolyzing triglycerides in circulating lipo-
proteins, which constitutes the rate-limiting step in removal
of triglyceride-rich lipoproteins, such as chylomicrons (CM)
and very low-density lipoproteins (VLDL) from the circula-
tion.2 Lipoprotein lipase is multifunctional enzyme, recently
shown to serve as a ligand for low-density lipoprotein (LDL)
receptor-related protein and to influence the hepatic secretion
and uptake of VLDL and LDL cholesterol.3
The LPL gene, located in region 8p22, is composed of 10
exons, 9 introns and contains some restriction fragment
length polymorphisms (RFLPs).4e6 Modifications in gene
structuremay affect LPL activity, resulting in lipidmetabolism
changes, such as slow hydrolysis of CM and VLDL, increased
half life of LDL and CM, lower production of high density li-
poproteins (HDL)7,8 and increased LPL activity.9 The HindIII
(rs320) polymorphism is one of the most common LPL gene
polymorphisms. It is an intronic base transition of thymine (T)
to guanine (G) at position þ495, which abolishes the restric-
tion site for the enzyme HindIII. Several studies have shown
that the common allele (Hþ) is significantly associated with
high triglycerides (TG) levels and low HDL levels compared to
the rare allele (H).10e16 The LPL Hþ Hþ genotype presented
elevated TG levels.17 Another study demonstrated that this
genotype has a higher risk of myocardial infarction (MI) in
patients over 90 years old, while H allele carriers are pro-
tected against MI.18
Hence, the present study was aimed at assessing the as-
sociation of the HindIII polymorphism of the LPL gene in MI
patients of a South Indian population. In addition to this,
classical risk factors and lipid profiles have been studied in all
the subjects.Table 1 e Demographic characteristics of the study
population.
Characteristics Controls
n ¼ 210(%)
MI patients
n ¼ 202(%)
AGE (Mean  SD) 61.3  4.6 63.2  3.96
Sex ratio (Male: Female) 184:26 181:21
BMI (Kg/m2) (Mean  SD) 22.4  2.5 28.1  1.7
Smokers 11 (5.2) 65 (32.1)
Alcoholic 17 (8.0)) 75 (37.1)
Exercise 117 (55.7) 16 (32.3)
Hypertension 0 66 (29.5)
MI ¼ myocardial infarction; SD ¼ standard deviation; BMI ¼ body
mass index.2. Methods
The study was carried out on 202 MI patients
(male:female¼ 181:21) admitted to Osmania General Hospital,
ICCU, Cardiology Division, Hyderabad, Andhra Pradesh, India.
The patients were 54e68 years of age. The inclusion criteria
for the current study was the patients with acute myocardial
infarction who underwent coronary angiography, where as
the patients with past history of coronary artery and vascular
diseases, pulmonary, renal, hepatic disease were excluded
from our study. For the present study, the selection of MI
patient study group were free of diabetes. The reason is that
Diabetes is a major risk factor for MI and it is well proven that
LPL gene HindIII gene polymorphism is associated with lipid
levels in diabetic patients. The present study was aimed to
find out the association between LPL HindIII polymorphism
and abnormal lipid levels in MI patients. On the basis of
typical ECG changes, elevated cardiac markers and clinical
history, the diagnosis was confirmed as MI by the cardiolo-
gists. The study was approved by the Ethical Committee and
written informed consent was obtained from all the subjects.
Blood samples were collected from patients after 13e15 h of
fasting. Simultaneously, blood samples were collected from
210 healthy, age- and sex-matched (male: female ¼ 184:26)controls (blood donors from the same hospital) aged between
56 and 67 years and all controls were non-hypertensive.
Information has been collected using a questionnaire on
age, sex, height, weight (for calculating body mass index),
cigarette smoking, exercise schedule, alcohol consumption
and hypertension. Exercise criteria were defined by an indi-
vidual doing 1 h daily in the form of brisk walking or gym
activity. Hypertension was defined according to JNC-VII
guidelines. Accordingly, hypertension was defined as a sys-
tolic blood pressure >140 mmHg and/or a diastolic blood
pressure >90 mmHg, based on the average of two blood
pressure measurements, or a patient’s self reported history of
hypertension. Smokers were defined as those reporting daily
smoking. Ex-smokers and occasional smokers were classified
as non-smokers. Since patients were found to drink alcohol in
different forms and many were reluctant to admit the exact
amount consumed, we defined alcohol usage as consumption
of at least three alcoholic drinks in a week.
To do the genotyping of LPL HindIII Polymorphism, 5 ml
venous blood was collected in a plain test tube and serum
was separated. In the region of intron 8, the LPL gene
containing HindIII polymorphism was amplified using the
following primers: forward primer 50-GATGTCTACCTGGATAA
TCAAAG-30and the reverse primer was 50-CTTCAGCTAGAC
ATTGCTAGTGT- 30. PCR reaction was carried out in a 50-uL re-
action volume containing 100 ng of genomicDNA, 0.4mmol/L of
each primer, 0.2 mmol/L dNTPs (Invitrogen, USA), 2 mmol/L
MgCl2 in 10% PCR buffer and 1 U of DNA polymerase. PCR
involvedan initial5-mindenaturationat 96 C, initialdenaturing
at 94 C for 1 min, annealing at 57 C for 1 min and extension at
72 C for 1min, with a final extension at 72 C for 7min, total 35
cycleswerekept.ThePCRamplified355-bpproductwasdigested
with 2.5 U of HindIII (MBI Ferments) at 37 C for 4 h, and the
fragments were separated on an ethidium bromide stained 2%
agarose gel; the replacement of a thymine (T)with a guanine (G)
base at position þ495 abolished the HindIII cleavage by convert-
ing the recognition sequence forHindIII (AAGCTT) into AAGCGT.
The presence of a 225-bp bandand a 140-bp band represents the
homozygousmutantHþHþ genotype; 365-bp, 225-bpand140-bp
bands represent the heterozygous Hþ H genotype; and 365-bp
bands represent the homozygous H H genotype. Total
cholesterol (TCL), triglycerides (TGL), high-density lipoprotein
(HDL), low-density lipoprotein (LDL) and very low-density lipo-
protein (VLDL) were estimated using a semi-automatic analyzer
Table 2 e Comparison of lipid profiles between MI
patients and controls.
Parameters Controls
(Mean  SD)
Patients
(mean  SD)
t value p value
TCL (mg/dl) 168.3  24.0 239.8  29.0 27.3 0.0001
TGL (mg/dl) 137.8  1.5 177.3  11.6 48.9 0.0001
LDL (mg/dl) 98.5  11.9 173.6  28.4 35.2 0.0001
HDL (mg/dl) 42.3  5.3 33.8  3.6 18.3 0.0001
VLDL (mg/dl) 27.3  1.3 36.6  1.9 58.1 0.0001
Values represent mean  standard deviation. MI ¼ myocardial
infarction; TCL ¼ total cholesterol; TGL ¼ triglycerides; LDL ¼ low-
density lipoprotein; HDL ¼ high-density lipoprotein; VLDL ¼ very-
low-density lipoprotein.
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mercial kits (ERBA).2.1. Statistics
Analysis of variance (ANOVA) test was performed for lipid
profiles among controls and MI patients using SPSS soft-
ware, 15.0 Windows version. For all cases, p < 0.05 was
considered significant. HardyeWeinberg law of equilibrium
was tested for the LPL gene polymorphism in controls and
MI patients, the genotype frequencies were in agreement
with the law. The association between genotypes of MI
patients and controls was examined by using the odds ratio
(OR) with 95% confidence interval (CI) and chi-square
analysis. Allelic frequencies for the HindIII polymorphic
site were estimated by gene counting. Multivariate logistic
regression analysis was done for adjusting the confounding
factors with LPL genotypes.3. Results
The demographic and clinical characteristics of the 210 con-
trols and 202MI patients are represented in Table 1. Themean
age of the controls and patients were 61.3 4.6 and 63.2 3.96
years respectively. The sex ratios were comparable in both
groups. The Body Mass Index was higher in MI subjects, as
compared to controls. Smokers and alcoholics were predom-
inant among patients. Only 32.3% were involved in exercise
among MI subjects against 55.7% among controls.Table 3 e Association of LPL genotypes with lipid levels in MI
Parameters
H H H Hþ
TCL (mg/dl) 215.8  29.1 237.1  29.8
TGL (mg/dl) 172.4  11.9 179.7  11.2
LDL (mg/dl) 168.2  29.1 170.1  27.6
HDL (mg/dl) 35.6  3.2 34.2  3.7
VLDL (mg/dl) 32.6  2.1 39.3  1.8
Values represent mean  standard deviation. MI ¼ myocardial infarctio
poprotein; HDL ¼ high-density lipoprotein; VLDL ¼ very-low-density lipoHypertensive individuals were excluded among controls,
where as 29.5% among MI patients.
The comparison of lipid profiles between controls and pa-
tients are showed in Table 2. The TCL, TGL, LDL and VLDL
levels were significantly high in patients in comparison with
controls (p ¼ 0.0001), where as the HDL levels were signifi-
cantly high in controls than in patients (p ¼ 0.0001). The as-
sociation of LPL genotypes with lipid levels between MI
patients and controls are summarised in Tables 3 and 4.
The distribution of LPL genotypes and allelic frequencies of
the study groups are presented in Table 5. The genotypic as-
sociation between patients and controls were shown in
Table 6. The Hþ Hþ vs. H H was c2 ¼ 19.4, OR 3.1, CI 95%
1.8e5.2, p< 0.0001; HþHþ vs. HþHwas c2¼ 1.4, OR 1.3, CI 95%
0.8e2.0, p > 0.22; Hþ Hþ vs. H H þ Hþ H was c2 ¼ 5.7, OR
0.64, CI 95% 0.4e0.9, p < 0.01. Hþ allele was significantly
associated with MI: Hþ vs. H was c2 ¼ 23.8, OR 2.0, CI 95%
1.5e2.6, p < 0.0001.
Multivariate logistic regression analysis was done for
adjusting the confounding factors with LPL genotypes. After
adjusting the all confounding factors we observed that Ho-
mozygous (HþHþ) mutation shows 33 times andHeterozygous
(Hþ H) genotype shows 6 times risk of MI as compared with
Homozygous (H H) genotype.4. Discussion
LPL plays a central role in the metabolism of lipoproteins and
associated with the development of atherosclerosis and cor-
onary heart disease (CHD). LPL gene mutants have been
extensively described in human. Number of studies have been
focused on the influence of LPL HindIII polymorphism on
plasma TG, TC, HDL-C and apolipoproteins levels; however
the results are inconsistent.19e21 Although LPL HindIII (rs320)
polymorphism is not expected to have any direct functional
effect on LPL activity, some of data have demonstrated that
Hþ allele is associated with higher TG, lower HDL-C level,
hyper triglyceridemia, the severity of atherosclerosis and an
increased risk of coronary artery disease (CAD).22
We examined the impact of genetic variants of the LPL gene
on plasma lipid levels in South Indian population. To our
knowledge, this is the first study of its kind in South Indians, a
population with very high rates of premature CAD.23
The present study investigated the role of this poly-
morphism in the development of MI. The frequencies of thepatients.
Genotypes
Hþ Hþ F value p value
266.7  28.1 45 0.001
180.0  11.7 5.6 0.004
182.5  28.5 5.3 0.005
31.6  3.9 18.2 0.001
37.9  2.0 80 0.0001
n; TCL ¼ total cholesterol; TGL ¼ triglycerides; LDL ¼ low-density li-
protein.
Table 4 e Association of LPL genotypes with lipid levels in controls.
Parameters Genotypes
H H H Hþ Hþ Hþ F value p value
TCL (mg/dl) 164.6  21.6 166.1  26.2 174.2  24.2 3.2 0.04
TGL (mg/dl) 134.8  1.4 135.6  1.2 143.0  1.9 25 0.01
LDL (mg/dl) 95.8  12.1 97.3  11.8 102.4  12.0 5.8 0.03
HDL (mg/dl) 44.2  4.9 42.8  5.4 40.1  5.6 10.9 0.03
VLDL (mg/dl) 25.3  1.1 28.6  1.5 28.0  1.3 28 0.01
Values represent mean  standard deviation. TCL ¼ total cholesterol; TGL ¼ triglycerides; LDL ¼ low-density lipoprotein; HDL ¼ high-density
lipoprotein; VLDL ¼ very-low-density lipoprotein.
Table 5 e Distribution of LPL genotypes and allelic frequencies of the study population.
Study group LPL genotypes Total Allelic frequencies Total
H H H Hþ Hþ Hþ H Hþ
Controls 72 (34.3) 68 (32.4) 70 (33.3) 210 0.51 0.49 420
Patients 32 (15.9) 72 (35.6) 98 (48.5) 202 0.34 0.64 404
LPL: Lipoprotein lipase gene; Percentages provided in parentheses.
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patients compared with controls, indicating the association of
LPL gene HindIII polymorphism with the disease. The results
of the present study were in accordance with observations of
earlier investigators, which support that Hþ Hþ genotype
associated with myocardial infarction.24
Several researchers have identified a significant associa-
tion between the Hþ allele and MI25, while others have shown
an association with CAD.26,27 We also got the results with a
strong association between the Hþ allele and MI .The ECTIM
caseecontrol study reported an increased odds ratio (2.1) for
MI with HindIII (Hþ Hþ) compared with HindIII (H H) geno-
types. A higher frequency of the Hþ allele is reported in pa-
tients with Alzheimer’s disease (AD) compared to a control
group, suggesting an increased risk of AD in Hþ allele carriers
indicating that LPL gene HindIII polymorphism showed asso-
ciation with Alzheimer disease.28
Thorn et al, (1990) observed a higher frequency of the Hþ
allele in patients with atherosclerosis and a recent study
showed an association with higher levels of TG, lower levels of
HDL, atherosclerosis severity and increased risk of CAD.29 A
study of elderly Russian MI patients and elderly controls (>90Table 6 e Distribution of LPL genotypes between MI
patients and controls for statistical significance.
Genotypes &
alleles (Patients
vs. controls)
Chi-square
(c2)
Odds
ratio
CI 95%
L. limit U. limit p value
Hþ Hþ vs. H H 19.4 3.1 1.8 5.2 0.0001
Hþ Hþ vs. Hþ H 1.4 1.3 0.8 2.0 0.22
Hþ Hþ vs. H H
þ Hþ H
5.7 0.64 0.4 0.9 0.01
Hþ vs. H 23.8 2.0 1.5 2.6 0.0001
LPL ¼ Lipoprotein lipase gene; MI ¼ myocardial infarction;
CI ¼ confidence interval; L ¼ lower; U ¼ upper.years) showedaprotectiveeffectof theHeallele.18A lipidprofile
with high TG and low HDL is a risk factor for atherosclerosis,
whichwas associatedwith theHþ allele in several populations
and italsoproved thatpolymorphicHindIIIsite in theLPLgene is
functional because it affects the binding of a transcription fac-
tor and it also has an impact on LPL expression.29
In the present study, 202 patients and 210 controls were
included and our selection criteria were specific for patients
with a first MI without previous history of vascular disease.
However, patients with cancer, neurological and all kidney
diseases were excluded from the study. The classical risk
factors and lipid profiles were significantly high in patients in
comparison with controls, which is consistent with previous
studies.19 We have observed that the LPL gene HindIII Hþ Hþ
genotype frequency was significantly associated with MI pa-
tients in South Indian population. Similar results on MI in
Brazil and Russian population have been observed.24 Infact,
studies on the LPL gene HindIII polymorphism are very limited
in India. Moreover, there are no reports on the LPL gene HindIII
polymorphism in MI from an Indian population.
To the best of our knowledge, this is the first study to
investigate the association of the LPL gene HindIII poly-
morphism in MI in a South Indian population. However, it
warrants further study in a larger cohort to confirm the as-
sociation of this gene polymorphism.5. Conclusion
Our data strongly suggest that the LPL gene HindIII Hþ Hþ ge-
notype is a independent risk factor for first MI.Conflicts of interest
All authors have none to declare.
i n d i a n h e a r t j o u rn a l 6 5 ( 2 0 1 3 ) 6 5 3e6 5 7 657Acknowledgments
We thank the patients and their families for their valuable
contribution. We also thank N. Bala Krishna for performing
the statistical analysis and Sreenivas Adurthi for their help in
editing the paper.r e f e r e n c e s
1. Braunwald E, ed. Heart Disease: A Textbook of Cardiovascular
Medicine. Philadelphia: W.B. Saunders; 1997.
2. Eckel RH. Lipoprotein lipase: a multifunctional enzyme
relevant to common metabolic diseases. N Engl J Med.
1989;320:1060e1068.
3. Mulder M, Lombardi P, Jansen H, et al. Low density
lipoprotein receptor internalizes low density and very low
density lipoproteins that are bound to heparin sulfate
proteoglycans via lipoprotein lipase. J Biol Chem.
1993;268:9369e9937.
4. Oka K, Tkalcevic GT, Nakano T, et al. Structure and
polymorphic map of human lipoprotein lipase gene. Biochim
Biophys Acta. 1990;1049:21e26.
5. Deeb SS, Peng RL. Structure of the human lipoprotein lipase
gene. Biochemistry. 1989;28:4131e4135.
6. Gotoda T, Yamada N, Murase T, et al. Detection of three
separate DNA polymorphisms in the human lipoprotein
lipase gene by gene amplification and restriction
endonuclease digestion. J Lipid Res. 1992;33:1067e1072.
7. Heizmann C, Kirchgessner T, Kwiterovich PO, et al. DNA
polymorphism haplotypes of the human lipoprotein lipase
gene: possible association with high density lipoprotein
levels. Hum Genet. 1991;86:578e584.
8. Gerdes C, Gerdes LU, Hansen PS, et al. Polymorphisms in the
lipoprotein lipase gene and their associations with plasma
lipid concentrations in 40-year-old Danish men. Circulation.
1995;92:1765e1769.
9. Stocks J, Thorn JA, Galton DJ. Lipoprotein lipase genotypes for
a common premature termination codon mutation detected
by PCR-mediated site-directed mutagenesis and restriction
digestion. J Lipid Res. 1992;33:853e857.
10. Peacock RE, Hamsten A, Nilsson-Ehle P, et al. Associations
between lipoprotein lipase gene polymorphisms and plasma
correlations of lipids, lipoproteins and lipase activities in
young myocardial infarction survivors and age-matched
healthy individuals from Sweden. Atherosclerosis.
1992;97:171e185.
11. Georges JL, Regis-Bailly A, Salah D, et al. Family study of
lipoprotein lipase gene polymorphisms and plasma
triglyceride levels. Genet Epidemiol. 1996;13:179e192.
12. Mattu RK, Needham EW, Morgan R, et al. DNA variants at the
LPL gene locus associate with angiographically defined
severity of atherosclerosis and serum lipoprotein levels in a
Welsh population. Arterioscler Thromb Vasc Biol.
1994;14:1090e1097.13. Mitchell RJ, Earl L, Bray P, et al. DNA polymorphisms at the
lipoprotein lipase gene and their association with
quantitative variation in plasma high-density lipoproteins
and triacylglycerides. Hum Biol. 1994;66:383e397.
14. Chamberlain JC, Thorn JA, Oka K, et al. DNA polymorphisms
at the lipoprotein lipase gene: associations in normal and
hypertriglyceridemia subjects. Atherosclerosis. 1989;79:85e91.
15. Thorn JA, Chamberlain JC, Alcolado JC, et al. Lipoprotein and
hepatic lipase gene variants in coronary atherosclerosis.
Atherosclerosis. 1990;85:55e60.
16. Razzaghi H, Aston CE, Hamman RF, et al. Genetic screening of
the lipoprotein lipase gene for mutations associated with
high triglyceride/low HDL-cholesterol levels. Hum Genet.
2000;107:257e267.
17. Ahn YI, Kamboh MI, Hamman RF, et al. Two DNA
polymorphisms in the lipoprotein lipase gene and their
associations with factors related to cardiovascular disease. J
Lipid Res. 1993;34:421e428.
18. Malygina NA, Melent’ev AS, Kostomarova IV, et al.
Connection of HindIII-polymorphism in the lipoprotein lipase
gene with myocardial infarct and life span in elderly ischemic
heart disease patients. Mol Biol (Mosk). 2001;35:787e791.
19. Ma YQ, Thomas GN, Ng MC, et al. The lipoprotein Lipase gene
HindIII polymorphism is associated with lipid levels in early-
onset type 2 diabetic patients. Metabolism. 2003;52:338e343.
20. Merkel M, Eckel RH, Goldberg IJ. Lipoprotein lipase: genetics,
lipid uptake, and regulation. J Lipid Res. 2002;43:1997e2006.
21. Murthy V, Julien P, Gagne C. Molecular path biology of the
human lipoprotein lipase gene. Pharmacol Ther.
1996;70:101e135.
22. Ye P, Pei L, Wang S. Polymorphisms of the human lipoprotein
lipase gene: possible association with lipid levels in patients
with coronary heart disease in Beijingarea. Chin Med Sci J.
1996;11:157e161.
23. Mohan V, Deepa R. Risk factors for coronary artery disease in
Indians. J Assoc Physicians India. 2004;52:95e97.
24. Gigek Cde O, Chen ES, Cendoroglo MS, et al. Association of
lipase lipoprotein polymorphism with myocardial infarction
and lipid levels. Clin Chem Lab Med. 2007;45:599e604.
25. Jemaa R, Fumeron F, Poirier O, et al. Lipoprotein lipase gene
polymorphisms: associations with myocardial infarction and
lipoprotein levels, the ECTIM study. Etude Cas Temoin sur
l’Infarctus du Myocarde. J Lipid Res. 1995;6:2141e2146.
26. Anderson JL, King GJ, Bair TL, et al. Association of lipoprotein
lipase gene polymorphisms with coronary artery disease. J
Am Coll Cardiol. 1999;33:1013e1020.
27. Long S, Tian Y, Zhang R, et al. Relationship between plasma
HDL subclasses distribution and lipoprotein lipase gene
HindIII polymorphism in hyperlipidemia. Clin Chim Acta.
2006;366:316e321.
28. Scacchi R, Gambina G, Broggio E, et al. The Hþ allele of the
lipoprotein lipase (LPL) HindIII intronic polymorphism and
the risk for sporadic late-onset Alzheimer’s disease. Neurosci
Lett. 2004;367:177e180.
29. Chen Q, Razzaghi 1 Hamid, Demirci FY, et al. Functional
Significance of lipoprotein lipase HindIII polymorphism
associated with the risk of coronary artery disease.
Atherosclerosis. 2008 Sep;200:102e108. Epub 2008 Feb 1.
